EVELYN ECCLES: Open Payments
NPI 1366533689 · MANCHESTER, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,224 in 57 payments from 13 companies in 2025. Trend: 2023 $815 · 2024 $1,267 · 2025 $1,224
Food & beverage: $1,224
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $323 |
| PFIZER INC. | 16 | $321 |
| Lilly USA, LLC | 6 | $130 |
| Axsome Therapeutics, Inc. | 3 | $99 |
| Novo Nordisk Inc | 4 | $95 |
| ABBVIE INC. | 3 | $71 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| Verona Pharma, Inc. | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| OWP Pharmaceuticals, Inc. | 1 | $19 |
Products named: AIRSUPRA, ELIQUIS, MOUNJARO, Auvelity, PAXLOVID, PREVNAR 20, Wegovy, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
